Massimo Franchini Selected Research

Massimo Franchini Research Topics

Disease

120	Hemorrhage 07/2023 - 05/2002
88	Hemophilia A (Haemophilia) 05/2024 - 11/2003
43	COVID-19 04/2024 - 01/2020
41	Thrombosis (Thrombus) 04/2024 - 08/2004
38	Neoplasms (Cancer) 02/2024 - 01/2004
27	Infections 02/2024 - 05/2002
25	Venous Thromboembolism 10/2023 - 11/2007
22	von Willebrand Diseases (von Willebrand's Disease) 07/2023 - 06/2002
15	Cardiovascular Diseases (Cardiovascular Disease) 12/2019 - 01/2008
11	Thrombocytopenia (Thrombopenia) 08/2021 - 11/2002
11	Thrombotic Thrombocytopenic Purpura 01/2021 - 01/2006
11	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 11/2003
10	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2010 - 11/2002
9	Hemorrhagic Disorders (Hemorrhagic Diathesis) 10/2017 - 04/2006
9	Thrombophilia 01/2016 - 01/2007
9	Hemochromatosis (Bronze Diabetes) 11/2010 - 05/2003
8	Hemophilia B (Haemophilia B) 04/2023 - 10/2011
8	Wounds and Injuries (Trauma) 07/2017 - 10/2006
7	Communicable Diseases (Infectious Diseases) 10/2023 - 03/2006
7	Disseminated Intravascular Coagulation 10/2023 - 04/2004
7	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 03/2005
6	Atrial Fibrillation 07/2023 - 04/2006
6	Acute Coronary Syndrome 03/2013 - 12/2008
6	Vascular System Injuries 01/2010 - 01/2007
6	Iron Overload 03/2008 - 01/2004
5	Virus Diseases (Viral Diseases) 10/2022 - 01/2005
5	Inflammation (Inflammations) 01/2022 - 08/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2023 - 10/2009
4	Thromboembolism 02/2022 - 11/2008
4	Liver Diseases (Liver Disease) 07/2019 - 08/2007
4	Anemia 11/2010 - 03/2004
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2010 - 08/2005
4	Chronic Hepatitis C 06/2008 - 12/2004
4	Lymphoma (Lymphomas) 07/2007 - 11/2005
4	HIV Infections (HIV Infection) 01/2007 - 07/2003
3	Human Influenza (Influenza) 05/2024 - 02/2010
3	Disease Progression 12/2023 - 10/2011
3	Pulmonary Embolism 01/2016 - 06/2015

Drug/Important Bio-Agent (IBA)

60	Factor VIII (Coagulation Factor VIII)IBA 05/2024 - 11/2003
43	Blood Coagulation Factors (Coagulation Factor)IBA 11/2022 - 05/2002
29	AutoantibodiesIBA 05/2024 - 03/2005
28	von Willebrand FactorIBA 07/2023 - 07/2006
22	Hemostatics (Antihemorrhagics)IBA 01/2021 - 11/2004
21	AnticoagulantsIBA 10/2023 - 04/2007
20	Factor VIIa (Activated Factor VII)IBA 01/2019 - 06/2005
18	IsoantibodiesIBA 01/2019 - 11/2006
17	ABO Blood-Group SystemIBA 09/2023 - 07/2012
17	recombinant FVIIa (rFVIIa)FDA Link 09/2018 - 03/2005
17	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 09/2018 - 06/2002
15	Monoclonal AntibodiesIBA 04/2024 - 04/2006
15	AntibodiesIBA 02/2024 - 06/2005
15	Neutralizing AntibodiesIBA 12/2023 - 09/2018
15	Blood Group Antigens (Blood Groups)IBA 09/2023 - 06/2007
13	IronIBA 11/2017 - 05/2003
11	Fibrinogen (Factor I)FDA Link 09/2018 - 11/2003
11	Thrombin FDA Link 06/2015 - 01/2007
10	VaccinesIBA 12/2023 - 04/2010
10	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2008
9	Proteins (Proteins, Gene)FDA Link 02/2021 - 12/2005
9	Prothrombin (Factor II)IBA 01/2019 - 01/2005
9	Lipoprotein(a)IBA 09/2017 - 01/2007
8	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2023 - 01/2013
7	Antiviral Agents (Antivirals)IBA 12/2023 - 01/2007
7	Inosine Triphosphate (ITP)IBA 01/2010 - 11/2002
6	AntithrombinsIBA 01/2016 - 01/2005
6	thiamine triphosphorate (TTP)IBA 10/2015 - 01/2006
6	Rituximab (Mabthera)FDA Link 07/2015 - 11/2005
5	Immunoglobulins (Immunoglobulin)IBA 02/2024 - 12/2005
5	fibrin fragment D (D-dimer)IBA 10/2023 - 01/2008
5	FibrinIBA 10/2023 - 04/2004
5	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2023 - 02/2010
5	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 09/2005
5	Tranexamic Acid (AMCA)FDA Link 01/2020 - 01/2011
5	Factor V (Coagulation Factor V)IBA 09/2018 - 02/2005
5	Protein CIBA 01/2016 - 11/2008
5	factor V LeidenIBA 01/2016 - 01/2005
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2014 - 06/2007
5	von Willebrand factor drug combination factor VIIIIBA 01/2010 - 11/2003
5	Blood Proteins (Serum Proteins)IBA 01/2010 - 01/2007
5	InterferonsIBA 06/2008 - 04/2003
4	emicizumabIBA 11/2022 - 01/2019
4	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2018 - 11/2004
4	Factor VII (Proconvertin)IBA 09/2018 - 02/2010
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2017 - 01/2007
4	AntigensIBA 07/2017 - 10/2008
4	prothrombin complex concentrates (PPSB)IBA 10/2016 - 08/2006
4	Vitamin K FDA Link 01/2016 - 10/2009
4	Thromboplastin (Tissue Factor)IBA 07/2011 - 08/2007
4	Dacarbazine (DIC)FDA LinkGeneric 06/2010 - 04/2004
3	remdesivirIBA 02/2024 - 06/2023
3	COVID-19 VaccinesIBA 01/2023 - 01/2021
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 10/2012
3	C-Reactive ProteinIBA 12/2020 - 06/2008
3	Factor XIII (Coagulation Factor XIII)IBA 09/2018 - 01/2007
3	PlasminogenIBA 01/2016 - 08/2007

Therapy/Procedure

106	Therapeutics 04/2024 - 06/2002
5	Operative Surgical Procedures 02/2016 - 01/2005
4	Immunotherapy 05/2024 - 02/2021
4	Drug Therapy (Chemotherapy) 10/2012 - 11/2005
4	Blood Transfusion (Blood Transfusions) 02/2011 - 03/2007